[1]
Kułak W., Sobaniec W.: Współczesne dane na temat uszkodzenia komórki
nerwowej. Medycyna 2000, 1991:15/16, 24–27.
[2]
Kułak W., Sobaniec W., Wojtal K. et al.: Calcium modulation in epilepsy.
Pol. J. Pharmacol., 2004:56, 29–41.
[3]
Choi DW.: Excitotoxic cell death. J. Neurobiol., 1992:23, 1261–1276.
[4]
Artemowicz B., Sobaniec W.: Rola aminokwasów pobudzających w
padaczce i drgawkach. Epileptologia, 1997:5, 189–207.
[5]
Sadurska B., Szumiało M.: Fosfolipazy A w komórkach ssaków – budowa,
właściwości, rola fizjologiczna i patologiczna. Post. Hig. Med. Dosw.,
2005:59, 116–123.
[6]
Muir K.W., Tyrrell P., Sattar N., Warburton E.: Inflammation and ischaemic stroke. Curr. Opin. Neurol., 2007:20, 334–342.
[7]
Rejdak K.: Strategie neuroprotekcyjne w postępowaniu z pacjentem z
udarem niedokrwiennym mózgu. Neurol. Prakt., 2007:5, 8–14.
[8]
Graham S.H., Chen J.: Programmed cell death in cerebral ischemia. J.
Cereb. Blood Flow Metab., 2001:21, 99–109.
[9]
Yakovlev A.G., Faden A.I.: Mechanism of neural cell death: implications
for development of neuroprotective strategies. Neuro Rx, 2004:1, 5–16.
[10]
Formigli L., Papucci L., Tani A. et al.: Aponecrosis: morphological and
biochemical exploration of a syncretic process of cell death sharing
apoptosis and necrosis. J. Cell Physiol., 2000:182, 41–49.
[11]
Sendrowski K., Sobaniec-Łotowska M.E., Sobaniec W.: Aponecrosis
of hippocampal neuronal cells in the experimental model of valproate
encephalopathy. Acta Neuropathol., 2004:108, 364 (abstract).
[12]
Sobaniec W., Kułak W., Boćkowski L. et al.: Badania procesów uszkodzenia układu nerwowego i możliwości neuroprotekcji. Przeg. Lek., 2001:58
(Suppl. 1), 41–47.
[13]
Ferro D.M.: Protecting neurons. Epilepsia, 2005:46 (Suppl. 7), 45–51.
[14]
Mains R.E., Patterson P.H.: Primary cultures of disssociated sympathetic
neurons. Establishment of long-term growth in culture and studies of
differentiated properties. J. Cell Biol., 1973:59, 329–345.
[15]
Fischbach G.D., Dichter M.A.: Electrophysiologic and morphologic properties of neurons in dissociated chick spinal cord cells cultures. Dev.
Biol., 1974:37, 100–116.
[16]
Lasher L.S.: The uptake of [3H] GABA and differentiation of stellate
neurons in cultures of dissociated postnatal rat cerebellum. Brain Res.,
1974:69, 235–254.
[17]
Banker G.A, Cowan W.M.: Rat hippocampal neurons in dispersed cell
culture. Brain Res., 1977:126, 297–342.
[18]
Super H., Soriano E.: The organization of the embryonic and early postnatal murine hippocampus. II. Development of entorhinal, commissural,
and septal connections studied with the lipophilic tracer DiI. J. Comp.
Neurol., 1994:344, 101–120.
[19]
Phelps E.: Human emotion and memory: interactions of the amygdale
and hippocampal complex. Curr. Opin. Neurobiol., 2004:14, 198–202.
[20]
Laakso M. MRI of hippocampus in incipient Alzheimer’s disease. 1996,
URL: http://www.uku.fi/neuro/37the.htm
[21]
Sendrowski K., Sobaniec W., Sobaniec-Łotowska M., Artemowicz B.:
Topiramate as a neuroprotectant in the experimental model of febrile
seizures. Adv. Med. Sc., 2007:52 (Suppl. 1), 161–165.
[22]
Conn P.J., Pin J.P.: Pharmacology and functions of metabotropic glutamate receptors. Ann. Rev. Pharmacol. Toxicol., 1997:37, 205–237.
[23]
Romijn H. J., Van Huizen F., Walters P. S.: Towards an improved serumfree, chemically defined medium for long-term culturing of cerebral
cortex tissue. Neurosci. Biobehav. Rev., 1984:8, 301–334.
[24]
Romijn H. J.: Development and advantages of serum-free, chemically
defined nutrient media for culturing of nerve tissue. Biol. Cell, 1988:63,
263–268.
[25]
Brewer G.J., Torricelli J.R., Evege E.K. et al.: Optimized survival of hippocampal neurons in B27-supplemented neurobasal, a new serum-free
medium combination. J. Neurosci. Res., 1993:35, 567–576.
[26]
Brewer G.J.: Isolation and culture of adult rat hippocampal neurons. J.
Neurosci. Methods, 1997:71, 143–155.
[27]
Mattson M.P., Barger S.W., Begley J.G. et al.: Calcium, free radicals, and
excitotoxic neuronal death in primary cell culture. Methods Cell Biol.,
1995:46, 187–216.
[28]
Xie C, Markesbery WR, Lovell MA.: Survival of hippocampal and cortical neurons in a mixture of MEM+ and B27-supplemented Neurobasal
medium. Free Radical Biol. Med., 2000:5, 665–672.
[29]
Brewer G.J., Torricelli J.R.: Isolation and culture of adult neurons and
neurospheres. Nat. Protocol, 2007:6, 1–9.
[30]
Poindron P., Piguet P., Forster E. (eds.): New methods for culturing cells
from nervous tissues. Bio Valley Monogr., Karger, Basel, 2005.
[31]
Letorneau P.C.: Cell-to-substratum adhesion in neuronal morphogenesis.
Dev. Biol., 1975:44, 92–101.
[32]
Mercurio A.M.: Laminin: multiple forms, multiple receptors. Curr. Opin.
Cell Biol., 1990:2, 845849.
[33]
Ray J., Peterson D.A., Schinstine M. et al.: Proliferation, differentiation
and long-term culture of primary hippocampal neurons. Proc. Natl. Acad.
Sci. USA, 1993:90, 3602–3606.
[34]
Ren R.F., Flanders K.C.: Transforming growth factors-beta protect primary rat hippocampal neuronal cultures from degeneration induced by
beta-amyloid peptide. Brain Res., 1996:732, 16–24.
[35]
Paula-Lima A.C., De Felice F.G., Brito-Moreira J. et al.: Activation of
GABA(A) receptors by taurine and muscimol blocks the neurotoxicity of
beta-amyloid in rat hippocampal and cortical neurons. Neuropharmacology, 2005:49, 1140–1148.
[36]
Kajta M., Lasoń W., Bień E. et al.: Neuroprotective effect of estrone on
NMDA-induced toxicity in primary cultures of rat cortical neurons are
independent of estrogen receptors. Pol. J. Pharmacol., 2002:54, 727–
729.
[37]
McDonnell J.W., Johnston M.V.: Physiological and pathophysiological
roles of excitatory amino acids during central nervous system development. Brain Res. Rev., 1990:15, 41–70.
[38]
Barth A., Barth L., Morrison R.S. et al.: bFGF enhances the protective
effects of MK-801 against ischemic neuronal injury in vitro. Neuroreport,
1996:7, 1461–1464.
[39]
Pringle A.K., Iannotti F., Wilde G.J. et al.: Neuroprotection by both NMDA
and non-NMDA receptor antagonists in in vitro ischemia. Brain Res.,
1997:755, 36–46.
[40]
May P.C., Robison P.M., Fuson K.S.: Stereoselective neuroprotection by
novel 2,3-benzodiazepine non-competitive AMPA antagonist against
non-NMDA receptor-mediated excitotoxicity in primary rat hippocampal
cultures. Neurosci. Lett., 1999:262, 219–221.
[41]
Adamchik Y., Baskys A.: Glutamate-mediated neuroprotection against
N-methyl-D-aspartate toxicity: a role for metabotropic glutamate receptors. Neuroscience, 2000:99, 731–736.
[42]
Kristensen B.W., Noraberg J., Zimmer J.: The GABA(A) receptor agonist
THIP is neuroprotective in organotypic hippocampal slice cultures. Brain
Res., 2003:973, 303–306.
[43]
Barone F.C., Lysko P.G., Price W.J. et al.: SB 201823-A antagonizes calcium currents in central neurons and reduces the effects of focal ischemia in rats and mice. Stroke, 1995:26, 1683–1689.
[44]
Jellinck P.H., Lee S.J., McEwen B.S.: Metabolism of dehydroepiandrosterone by rat hippocampal cells in culture: possible role of aromatization
and 7-hydroxylation in neuroprotection. J. Steroid Biochem. Mol. Biol.,
2001:78, 313–317.
[45]
Lipski J., Wan C.K., Bai J.Z. et al.: Neuroprotective potential of ceftriaxone in in vitro models of stroke. Neuroscience, 2007:146, 617–629.
[46]
Skaper S.D., Ancona B., Facci L. et al.: Melatonin prevents the delayed
death of hippocampal neurons induced by enhanced excitatory neurotransmission and the nitridergic pathway. FASEB J., 1998:12, 725–731.
[47]
Macdonald R.L.: Anticonvulsant drug actions on neurons in cell culture.
J. Neural. Transm., 1988:72, 173.
[48]
Frandsen A., Quistorff B., Schousboe A.: Phenobarbital protects cerebral
cortex neurones against toxicity induced by kainate but not by other
excitatory amino acids. Neurosci. Lett., 1990:111, 233–238.
[49]
Wallis R.A., Panizzon K.L., Fairchild M.D. et al.: Protective effects of felbamate against hypoxia in the rat hippocampal slice. Stroke, 1992:23,
547–551.
[50]
Poulsen C.F., Simeone T.A., Maar T.E. et al.: Modulation by topiramate
of AMPA and kainate mediated calcium influx in cultured cerebral cortical, hippocampal and cerebellar neurons. Neurochem. Res., 2004:29,
275–282.
[51]
Boscia F., Annunziato L., Taglialatela M.: Retigabine and flupirtine exert
neuroprotective actions in organotypic hippocampal cultures. Neuropharmacology, 2006:51, 283–294.
[52]
Guo X., Dillman J.F., Dawson V.L. et al.: Neuroimmunophilins: novel
neuroprotective and neurodegenerative targets. Ann. Neurol., 2001:50,
6–16.
[53]
Marsicano G., Goodenough S., Monory K. et al.: CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science, 2003:302,
84–88.
Scholar Google
PubMed